Learn how PTC Therapeutics developed our spinal muscular atrophy (SMA) therapy from our founder and CEO Stuart Peltz, VP & Head of Group External Affairs and Alliance Management Nikolai Naryshkin, and other members of our dedicated team.
SMA Therapy: A Winding Path to Success
Read Next
What You Need to Know About Ferroptosis
Our research efforts at PTC are focused on two scientific platforms – splicing and ferroptosis and inflammation – where...
Honoring International Women’s Day Through Inclusion and Pride
When asked why it’s important to recognize Women’s History Month (WHM) in March, women leaders at PTC agree: WHM...
In it Together: Rare Disease Day 2024
Rare Disease Day, which takes place every year on the last day of February, is a global movement aimed...